You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 諾誠健華-B(9969.HK)創歷史新高 八日累漲逾36%
格隆匯 04-22 14:16
格隆匯4月22日丨諾誠健華-B(9969.HK)大漲逾9%,報25.4港元,高見25.75港元刷新歷史新高,近八個交易日累漲逾36%,最新總市值381億港元。招銀國際研報顯示,諾誠健華於上週(4月16-18日)召開的中華醫學會第一次全國淋巴細胞疾病學術大會上公佈了BTK的最新臨牀數據,研究者評估其總緩解率(ORR)高達93.90%,其中完全緩解率達21.30%。BTK抑制劑具有廣闊市場空間,2018年BTK抑制劑全球市場份額為45億美元,預計2030年全球市場規模將達235億美元,中國市場規模將達26億美元。此外,諾誠健華已於4月2日同中金公司簽署上市輔導協議,並於近日在北京證監局備案,擬科創板二次上市。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account